2022 Catalog: All Courses
DE0385: Diabetes Online CDE: Pharmacovigilance: Timely Information Regarding Medication Safety
This seminar will discuss the role of pharmacovigilance within the Indian Health Service and provide information about medication safety as it relates to current issues and events.
Upon completion of this course, participants will be able to:
1. Describe the role of medication safety and the effects it has on safety, especially for people with diabetes and other chronic conditions.
2. Detect and report adverse drug or vaccine events to improve patient safety.
3. Examine the pharmacovigilance process utilized by the National Pharmacy and Therapeutics Committee and other IHS programs to prevent adverse drug events.
It is the policy of the Indian Health Service, Division of Oral Health, that faculty/planners disclose any financial or other relationships with commercial companies whose products may be discussed in the educational activity. The Indian Health Service, Division of Oral Health, also requires that faculty disclose any unlabeled or investigative use of pharmaceutical products and medical devices. Images that have been falsified or manipulated to misrepresent treatment outcomes are prohibited.
None of the faculty/planners for this activity has a conflict of interest, and there is no use of unlabeled or investigative pharmaceutical products or medical devices. No images have been falsified or manipulated to misrepresent treatment outcomes.The educational objectives, content, and selection of educational methods and instructors are conducted independent of any commercial entity.
Tuition must be paid in full 8 weeks prior to the start date of any course. Request for refunds must be received in writing at least two weeks before the course begins. For each refund request, there will be an administrative charge of $100. No refunds will be made to registrants who fail to attend a course. If IHS CDE program cancels a course, then 100% of the tuition will be refunded.